Global pharmaceutical company Galderma has appointed Kendrick PR and Mantlepiece PR as its new UK representatives.
The PR programme will be focusing on the Galderma injectables portfolio, including Sculptra, Restylane and Azzalure.
Julia Kendrick, founder of Kendrick PR, commented, “We are delighted to be bringing together the best of Kendrick and Mantelpiece. This will be a comprehensive PR programme for a market-leading company and given our respective years of expertise and strong networks, head of Mantlepiece PR Kate Zadah and I felt it was the ideal opportunity to work collaboratively to deliver some exciting and thought-provoking campaigns. Watch this space!”
